3-nitrotyrosine was elevated in CAD patients in the high- and low-HDL groups, although 3-nitrotyrosine and MPO-specific 3-chlorotyrosine were not correlated, indicating that 3-nitrotyrosine is derived from other RNS and not from MPO action. This evidence concerns the gene MPO and coronary artery disorder.